Modeling Simple Experimental Platform for In Vitro Study of Drug Elution from Drug Eluting Stents (DES)
نویسنده
چکیده
We present a simple model of experimental setup for in vitro study of drug release from drug eluting stents and drug propagation in artificial tissue samples representing blood vessels. The model is further reduced using the assumption on vastly different characteristic diffusion times in the stent coating and in the artificial tissue. The model is used to derive a relationship between the times at which the measurements have to be taken for two experimental platforms, with corresponding artificial tissue samples made of different materials with different drug diffusion coefficients, to properly compare the drug release characteristics of drug eluting stents.
منابع مشابه
A three-dimensional mathematical model for drug delivery from drug-eluting stents
Current drug-eluting stent (DES) technology is not optimized with regard to the pharmacokinetics of drug release, more research on the <span style="font-size: 12pt; color: #000000; font-style: normal; ...
متن کاملClinical review of the Resolute® zotarolimus-eluting stent for the treatment of coronary artery disease
Drug-eluting stents (DES) offer reduced rates of clinical and angiographic restenosis compared with bare-metal stents in patients with symptomatic coronary artery disease. Despite availability of multiple different DES, concerns remain regarding relative efficacy and long-term safety. A DES that has optimal efficacy that extends to higher risk cases – specifically to maintain low restenosis rat...
متن کاملThe Resolute™ Integrity Zotarolimus-Eluting Stent in Coronary Artery Disease: A Review
The introduction of first-generation drug-eluting stents (DES) was a major advance in the percutaneous treatment of coronary artery disease, with DES significantly reducing the incidence of restenosis and major adverse coronary events compared with bare metal stents. Next-generation DES now utilizes lower profiles, thinner struts, and other technological advances to help extend their safety and...
متن کاملDrug-eluting stents.
Coronary artery disease (CAD) is currently a leading cause of death worldwide. Drug-eluting stents (DESs) have been dominant for the treatment of CAD in the interventional cardiology world owing to their efficacy in significantly reducing restenosis. However, late stage stent thrombosis has become a major concern. Stent platform, drug delivery vehicle and type of drug are three parts of DES and...
متن کاملEvaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating.
OBJECTIVES We sought to evaluate a new second-generation drug-eluting stent (DES), comprising a slow-release biodegradable polylactide coglycolide (PLGA) polymer and low-dose paclitaxel on a thin-strut cobalt chromium stent platform, in a clinically relevant animal model. BACKGROUND Our previous work demonstrated subacute vascular toxicity and necrosis triggering late excess neointima in pig ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014